Year None202120202019201820172016 Date Latest Press Release December 16, 2019 Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies November 15, 2019 Eiger to Present at Jefferies 2019 London Healthcare Conference November 12, 2019 Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019 November 7, 2019 Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update October 21, 2019 Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019 September 27, 2019 Eiger to Present at Cantor 2019 Global Healthcare Conference August 29, 2019 Eiger BioPharmaceuticals to Participate in September Conferences August 20, 2019 Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection August 8, 2019 Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update August 5, 2019 Eiger BioPharmaceuticals to Participate in Investor Conferences in August Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
